Study about L-methylfolate

Study shows that a folic acid-like drug, L-methylfolate, has the ability to change the DNA process within a patients tumour.


According to the phase-1 clinical trail conducted at Vanderbilt University Medical Centre, it appears possible that the DNA methylome of these brain tumours can be reprogrammed when this potential drug was administered alongside the current standard therapy for recurrent glioblastomas.
about L-methylfolate
“This is an important first step in understanding how we can manipulate the epigenome, and hopefully, this study will help design future epigenetic studies in glioblastoma treatment,” said Stephen Clark, assistant professor of Neurology in the Division of Neuro-Oncology at Vanderbilt University Medical Centre.

Magnafolate® ,the Manufacturers & Supplier of L-methylfolate.
Previous:The Side Effects of Folic Acid Next:Folate Insufficiency in Second Trimester Increases Preterm Birth Risk by 80%! AJOG Study Reveals Critical Nutritional Window
Let's talk

We're Here to Help

Contact Us
 

展开
TOP